Rohto Pharmaceutical Co.,Ltd. (FRA:UC1)

Rohto Pharmaceutical Revenue

Rohto Pharmaceutical had revenue of 82.29B JPY in the quarter ending September 30, 2025, with 16.35% growth. This brings the company's revenue in the last twelve months to 333.80B, up 18.35% year-over-year. In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B with 13.95% growth.

• Revenue (ttm): 333.80B JPY
• Revenue Growth: +18.35%
• P/S Ratio: 1.64
• Revenue / Employee: 36.50M JPY
• Employees: 9,144
• Market Cap: 3.15B EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%